Showing results (71-80 of 246) with videos related to
Sort By:
Pageof 25
Circulation. Cardiovascular Quality and Outcomes|October 7, 2010
Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trialsMenno V Huisman, Daniel J Quinlan, Ola E Dahl, et al.Thrombosis and Haemostasis|January 18, 2006
Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VIISam Schulman, Geir E Tjønnfjord, Richard Wallensten, et al.Journal of Thrombosis and Haemostasis : JTH|April 8, 2025
Direct oral anticoagulant failure in patients with venous thromboembolism-why and what next?Dawn Swan, Robert Turner, Erik Lerkevang Grove, et al.Thrombosis and Haemostasis|November 5, 2005
Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatranHenry Eriksson, Torbjörn Lundström, Karin Wåhlander, et al.Thrombosis and Haemostasis|November 8, 2005
Ximelagatran for the secondary prevention of venous thromboembolism: a complementary follow-up analysis of the THRIVE III studySam Schulman, Torbjörn Lundström, Karin Wålander, et al.Stroke|October 30, 2010
Optimal timing of resumption of warfarin after intracranial hemorrhageAmmar Majeed, Yang-Ki Kim, Robin S Roberts, et al.European Journal of Gastroenterology & Hepatology|October 19, 2012
Bile acids and coagulation factors: paradoxical association in children with chronic liver diseaseMaria Magnusson, Björn Fischler, Jan Svensson, et al.Thrombosis and Haemostasis|September 30, 2003
Platelet-leukocyte aggregation under shear stress: differential involvement of selectins and integrinsHu Hu, David Varon, Paul Hjemdahl, et al.Chest|September 24, 2004
Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyMark N Levine, Gary Raskob, Rebecca J Beyth, et al.Thrombosis Research|September 28, 2018
Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin timeCatherine Dubé, James D Douketis, Karen A Moffat, et al.Pageof 25